The new crown epidemic has been raging around the world for three years. The release of new crown vaccine , new crown special drugs, and new crown testing test kits have caused the stock price of of some core concept stocks . The most well-known of them is Jiuan Medical , with the stock price directly rising from 5 yuan to 98 yuan, less than 20 times.
In 2022, with the evolution of the new coronavirus, the probability of pathogenicity has decreased. At the same time, my country has found that traditional Chinese medicine has more surprising effects in the treatment of new crown in the clinical treatment of new crown, so that the stock prices of some traditional Chinese medicine stocks take off directly.
So Chinese medicine stocks have risen for a while, does it still have investment value? Or many of us don’t know which target stock prices have room to double.
Next, Ahui will give you a brief analysis of the value logic of traditional Chinese medicine and the current relatively high-quality targets.
First of all, let’s look at the value logic of traditional Chinese medicine: traditional Chinese medicine has been one of the national treasures of our country since ancient times, and has a long history in our country. And it has made great contributions to the health of our people!
So the value of traditional Chinese medicine is self-evident, and the area of traditional Chinese medicine planting has continued to grow.
In 2019, China's traditional Chinese medicine planting area was 39 million mu; in 2020, my country's traditional Chinese medicine planting area was 40.2 million mu; in 2021, my country's traditional Chinese medicine planting area was 43 million mu; in 2022, China's traditional Chinese medicine planting area was 45 million mu;
As Chinese medicine plays an increasingly important role in the treatment of new crown, the demand is increasing. The area of Chinese medicine planting in my country is likely to continue to grow (because some Chinese patent medicines in my country are also involved in export business, just like Jiu'an Medical's antigen test kit.)
Secondly, let's take a look at the relatively high-quality targets in Chinese medicine stocks.
1. Yiling Pharmaceutical : Lianhua Qingwen Capsule in the clinical treatment of new crown is recognized, and the stock price has more than tripled since the end of September.
Yiling Pharmaceutical's current stock price is somewhat high. In the long run, Yiling Pharmaceutical has a market value of 100 billion yuan.
2. Stepan Pharmaceutical: Xuanfeibaidu Granule has performed very well in the treatment of new crown. The stock price has increased by 280% since the end of September.
step long pharmaceutical hit the daily limit on Friday, which was a rebound. After all, the increase has not doubled yet, so you can pay attention to it at low prices next.
3.Zhongsheng Pharmaceutical : The RAY1216 tablets intended for the treatment of patients infected with novel coronavirus (SARS-CoV-2) are undergoing phase III clinical study in , which is the reason why Zhongsheng Pharmaceutical's stock price tripled in just two months.
Zhongsheng Pharmaceutical's current stock price is loose at a high level. It is recommended that callback be followed before paying attention. After all, Zhongsheng Pharmaceutical's new crown special medicine is still a relatively leading technology in China, which is worth looking forward to.
4. Guizhou Bailing: Guizhou Bailing cough syrup shines on the weekend and has effect on mild patients in clinical treatment.
Guizhou Bailing's stock price is currently not high and deserves special attention.
5. Zhendong Pharmaceutical : Sophora ginseng , Astragalus , Forsythia , Codonopsis pilosula, Baituling , Chinese medicine planting area is 820,000 mu, and the planting area is still being expanded. At the same time, Zhendong Pharmaceutical is also a raw material supplier of Yiling Pharmaceutical, so it is worth paying attention to it.
6.Teyi Pharmaceutical : The stock price has tripled in just two months and is currently in a high-level pullback. You can pay attention at any time and wait patiently for stability while considering it.
There are still many traditional Chinese medicine stocks: Tailong Pharmaceutical , Kangyuan Pharmaceutical , Tongrentang , Hongri Pharmaceutical , and many more.
Ahui lists so many Chinese medicine stocks targets, and I think the traditional Chinese medicine sector has already achieved high growth.
Although many target stock prices have doubled, there are also many target stocks with excellent fundamentals and stock prices that are only started or low. It is worth our focus, because Chinese medicine has been practiced in these three years.Its position in my country's medical system is getting higher and higher, and the corresponding entire traditional Chinese medicine industry chain will also usher in better opportunities.
At the end of the article Ah Hui wants to say that no matter how good the target is, it needs to enter at a suitable price. Do not chase high and sell down .
Like and follow after reading it is a virtue. I wish you all good luck in the stock market!
(Disclaimer: The above content is for reference only and is not used as a basis for investment!)
